The wild-type hepatitis C virus core inhibits initiation of antigen-specific T- and B-cell immune responses in BALB/c mice

Clinical and Vaccine Immunology

Volumn 17, Issue 7, 2010, Pages 1139-1147

  Zhu, Wenbo ^a,d   Chang, Yanzi ^b   Wu, Chunchen ^a   Han, Qingxia ^a   Pei, Rongjuan ^a,d   Lu, Mengji ^a,b,c   Chen, Xinwen ^a  

^a WUHAN INSTITUTE OF VIROLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

^d UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CORE PROTEIN; DNA VACCINE; GAMMA INTERFERON; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; HEPATITIS C VACCINE; NUCLEOCAPSID PROTEIN, HEPATITIS C VIRUS; VIRUS ANTIGEN; VIRUS VACCINE;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; DNA IMMUNIZATION; ELECTROPORATION; FEMALE; HEPATITIS C; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOGENICITY; IMMUNOREACTIVITY; INFECTION RESISTANCE; INTERFERON PRODUCTION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; VIRUS CORE; ANIMAL; B LYMPHOCYTE; BAGG ALBINO MOUSE; HEPACIVIRUS; IMMUNITY; IMMUNOLOGY; T LYMPHOCYTE;

ANIMALS; ANTIGENS, VIRAL; B-LYMPHOCYTES; HEPACIVIRUS; IMMUNITY; MICE; MICE, INBRED BALB C; T-LYMPHOCYTES; VACCINES, DNA; VIRAL CORE PROTEINS; VIRAL VACCINES;

EID: 77954371853     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00490-09     Document Type: Article

References (52)

1. Alberti, A., A. Vario, A. Ferrari, and R. Pistis. 2005. Review article: chronic hepatitis C - natural history and cofactors. Aliment Pharmacol. Ther. 22(Suppl. 2):74-78.
2. Alekseeva, E., I. Sominskaya, D. Skrastina, I. Egorova, E. Starodubova, E. Kushners, M. Mihailova, N. Petrakova, R. Bruvere, T. Kozlovskaya, M. Isaguliants, and P. Pumpens. 2009. Enhancement of the expression of HCV core gene does not enhance core-specific immune response in DNA immunization: advantages of the heterologous DNA prime, protein boost immunization regiment. Genet. Vaccines Ther. 7:7.
3. Bain, C., A. Fatmi, F. Zoulim, J. P. Zarski, C. Trepo, and G. Inchauspe. 2001. Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. Gastroenterology 120:512-524. (Pubitemid 32147649)
4. Choo, Q. L., G. Kuo, A. J. Weiner, L. R. Overby, D. W. Bradley, and M. Houghton. 1989. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359-362.
5. Cramp, M. E., P. Carucci, S. Rossol, S. Chokshi, G. Maertens, R. Williams, and N. V. Naoumov. 1999. Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia. Gut 44:424-429.
6. Crotta, S., A. Stilla, A. Wack, A. D'Andrea, S. Nuti, U. D'Oro, M. Mosca, F. Filliponi, R. M. Brunetto, F. Bonino, S. Abrignani, and N. M. Valiante. 2002. Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J. Exp. Med. 195:35-41.
7. Dansako, H., A. Naganuma, T. Nakamura, F. Ikeda, A. Nozaki, and N. Kato. 2003. Differential activation of interferon-inducible genes by hepatitis C virus core protein mediated by the interferon stimulated response element. Virus Res. 97:17-30. (Pubitemid 37204905)
8. Dolganiuc, A., K. Kodys, A. Kopasz, C. Marshall, T. Do, L. Romics, Jr., P. Mandrekar, M. Zapp, and G. Szabo. 2003. Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation. J. Immunol. 170:5615-5624. (Pubitemid 36617852)
9. Duenas-Carrera, S., L. Alvarez-Lajonchere, J. C. Alvarez-Obregon, A. Herrera, L. J. Lorenzo, D. Pichardo, and J. Morales. 2000. A truncated variant of the hepatitis C virus core induces a slow but potent immune response in mice following DNA immunization. Vaccine 19:992-997.
10. Foy, E., K. Li, C. Wang, R. Sumpter, Jr., M. Ikeda, S. M. Lemon, and M. Gale, Jr. 2003. Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 300:1145-1148. (Pubitemid 36583099)
11. Freeman, A. J., Y. Pan, C. E. Harvey, J. J. Post, M. G. Law, P. A. White, W. D. Rawlinson, A. R. Lloyd, G. Marinos, and R. A. Ffrench. 2003. The presence of an intrahepatic cytotoxic T lymphocyte response is associated with low viral load in patients with chronic hepatitis C virus infection. J. Hepatol. 38:349-356.
12. Gehring, S., S. H. Gregory, N. Kuzushita, and J. R. Wands. 2005. Type 1 interferon augments DNA-based vaccination against hepatitis C virus core protein. J. Med. Virol. 75:249-257.
13. Gordon, E. J., R. Bhat, Q. Liu, Y. F. Wang, C. Tackney, and A. M. Prince. 2000. Immune responses to hepatitis C virus structural and nonstructural proteins induced by plasmid DNA immunizations. J. Infect. Dis. 181:42-50.
14. Hahn, C. S., Y. G. Cho, B. S. Kang, I. M. Lester, and Y. S. Hahn. 2000. The HCV core protein acts as a positive regulator of fas-mediated apoptosis in a human lymphoblastoid T cell line. Virology 276:127-137.
15. He, X. S., H. S. Chen, K. Chu, M. Rivkina, and W. S. Robinson. 1996. Costimulatory protein B7-1 enhances the cytotoxic T cell response and antibody response to hepatitis B surface antigen. Proc. Natl. Acad. Sci. U. S. A. 93:7274-7278.
16. Hijikata, M., N. Kato, Y. Ootsuyama, M. Nakagawa, and K. Shimotohno. 1991. Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proc. Natl. Acad. Sci. U. S. A. 88:5547-5551.
17. Hope, R. G., and J. McLauchlan. 2000. Sequence motifs required for lipid droplet association and protein stability are unique to the hepatitis C virus core protein. J. Gen. Virol. 81:1913-1925.
18. Hu, G. J., R. Y. Wang, D. S. Han, H. J. Alter, and J. W. Shih. 1999. Characterization of the humoral and cellular immune responses against hepatitis C virus core induced by DNA-based immunization. Vaccine 17: 3160-3170.
19. Hussy, P., H. Langen, J. Mous, and H. Jacobsen. 1996. Hepatitis C virus core protein: carboxy-terminal boundaries of two processed species suggest cleavage by a signal peptide peptidase. Virology 224:93-104. (Pubitemid 26358104)
20. Inchauspe, G., M. E. Major, I. Nakano, L. Vitvitski, and C. Trepo. 1997. DNA vaccination for the induction of immune responses against hepatitis C virus proteins. Vaccine 15:853-856. (Pubitemid 27287974)
21. + T-cells. Vaccine 22:1656-1665.
22. Kim, H. S., J. K. Lee, I. H. Yang, J. K. Ahn, Y. I. Oh, C. J. Kim, Y. S. Kim, and C. K. Lee. 2002. Identification of hepatitis C virus core domain inducing suppression of allostimulatory capacity of dendritic cells. Arch. Pharm. Res. 25:364-369.
23. Kittlesen, D. J., K. A. Chianese-Bullock, Z. Q. Yao, T. J. Braciale, and Y. S. Hahn. 2000. Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation. J. Clin. Invest. 106:1239-1249.
24. Koziel, M. J., D. K. Wong, D. Dudley, M. Houghton, and B. D. Walker. 1997. Hepatitis C virus-specific cytolytic T lymphocyte and T helper cell responses in seronegative persons. J. Infect. Dis. 176:859-866.
25. Lagging, L. M., K. Meyer, D. Hoft, M. Houghton, R. B. Belshe, and R. Ray. 1995. Immune responses to plasmid DNA encoding the hepatitis C virus core protein. J. Virol. 69:5859-5863.
26. Lee, C. H., Y. H. Choi, S. H. Yang, C. W. Lee, S. J. Ha, and Y. C. Sung. 2001. Hepatitis C virus core protein inhibits interleukin 12 and nitric oxide production from activated macrophages. Virology 279:271-279.
27. Liao, G., Y. Wang, J. Chang, T. Bian, W. Tan, M. Sun, W. Li, H. Yang, J. Chen, X. Zhang, S. Bi, M. Omata, and S. Jiang. 2008. Hepatitis B virus precore protein augments genetic immunizations of the truncated hepatitis C virus core in BALB/c mice. Hepatology 47:25-34. (Pubitemid 351171038)
28. Lin, W., S. S. Kim, E. Yeung, Y. Kamegaya, J. T. Blackard, K. A. Kim, M. J. Holtzman, and R. T. Chung. 2006. Hepatitis C virus core protein blocks interferon signaling by interaction with the STAT1 SH2 domain. J. Virol. 80:9226-9235. (Pubitemid 44359995)
29. Liu, Z. X., H. Nishida, J. W. He, M. M. Lai, N. Feng, and G. Dennert. 2002. Hepatitis C virus genotype 1b core protein does not exert immunomodulatory effects on virus-induced cellular immunity. J. Virol. 76:990-997.
30. Lo, S. Y., F. Masiarz, S. B. Hwang, M. M. Lai, and J. H. Ou. 1995. Differential subcellular localization of hepatitis C virus core gene products. Virology 213:455-461.
31. Mann, E. A., S. Stanford, and K. E. Sherman. 2006. Prevalence of mutations in hepatitis C virus core protein associated with alteration of NF-kappaB activation. Virus Res. 121:51-57.
32. Moorman, J. P., D. Prayther, D. McVay, Y. S. Hahn, and C. S. Hahn. 2003. The C-terminal region of hepatitis C core protein is required for Fas-ligand independent apoptosis in Jurkat cells by facilitating Fas oligomerization. Virology 312:320-329.
33. Moradpour, D., C. Englert, T. Wakita, and J. R. Wands. 1996. Characterization of cell lines allowing tightly regulated expression of hepatitis C virus core protein. Virology 222:51-63. (Pubitemid 26281358)
34. Ohkawa, K., H. Ishida, F. Nakanishi, A. Hosui, K. Ueda, T. Takehara, M. Hori, and N. Hayashi. 2004. Hepatitis C virus core functions as a suppressor of cyclin-dependent kinase-activating kinase and impairs cell cycle progression. J. Biol. Chem. 279:11719-11726.
35. Okamoto, H., F. Tsuda, A. Machida, E. Munekata, Y. Akahane, Y. Sugai, K. Mashiko, T. Mitsui, T. Tanaka, Y. Miyakawa, et al. 1992. Antibodies against synthetic oligopeptides deduced from the putative core gene for the diagnosis of hepatitis virus infection. Hepatology 15:180-186.
36. Poynard, T., M. F. Yuen, V. Ratziu, and C. L. Lai. 2003. Viral hepatitis C. Lancet 362:2095-2100.
37. Puig, M., M. E. Major, K. Mihalik, and S. M. Feinstone. 2004. Immunization of chimpanzees with an envelope protein-based vaccine enhances specific humoral and cellular immune responses that delay hepatitis C virus infection. Vaccine 22:991-1000. (Pubitemid 38221092)
38. Rehermann, B. 2007. Chronic infections with hepatotropic viruses: mechanisms of impairment of cellular immune responses. Semin. Liver Dis. 27: 152-160.
39. Rehermann, B., K. M. Chang, J. G. McHutchison, R. Kokka, M. Houghton, and F. V. Chisari. 1996. Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection. J. Clin. Invest. 98:1432-1440.
40. Rispeter, K., M. Lu, S. E. Behrens, C. Fumiko, T. Yoshida, and M. Roggendorf. 2000. Hepatitis C virus variability: sequence analysis of an isolate after 10 years of chronic infection. Virus Genes 21:179-188.
41. Santolini, E., G. Migliaccio, and N. La Monica. 1994. Biosynthesis and biochemical properties of the hepatitis C virus core protein. J. Virol. 68: 3631-3641. (Pubitemid 24177387)
42. Sarobe, P., J. J. Lasarte, N. Casares, A. Lopez-Diaz de Cerio, E. Baixeras, P. Labarga, N. Garcia, F. Borras-Cuesta, and J. Prieto. 2002. Abnormal priming of CD4(+) T cells by dendritic cells expressing hepatitis C virus core and E1 proteins. J. Virol. 76:5062-5070. (Pubitemid 34441711)
43. Sarobe, P., J. J. Lasarte, A. Zabaleta, L. Arribillaga, A. Arina, I. Melero, F. Borras-Cuesta, and J. Prieto. 2003. Hepatitis C virus structural proteins impair dendritic cell maturation and inhibit in vivo induction of cellular immune responses. J. Virol. 77:10862-10871. (Pubitemid 37204279)
44. Soguero, C., M. Joo, K. A. Chianese-Bullock, D. T. Nguyen, K. Tung, and Y. S. Hahn. 2002. Hepatitis C virus core protein leads to immune suppression and liver damage in a transgenic murine model. J. Virol. 76:9345-9354. (Pubitemid 34919892)
45. Suzuki, R., Y. Matsuura, T. Suzuki, A. Ando, J. Chiba, S. Harada, I. Saito, and T. Miyamura. 1995. Nuclear localization of the truncated hepatitis C virus core protein with its hydrophobic C terminus deleted. J. Gen. Virol. 76(Pt. 1):53-61.
46. Suzuki, R., S. Sakamoto, T. Tsutsumi, A. Rikimaru, K. Tanaka, T. Shimoike, K. Moriishi, T. Iwasaki, K. Mizumoto, Y. Matsuura, T. Miyamura, and T. Suzuki. 2005. Molecular determinants for subcellular localization of hepatitis C virus core protein. J. Virol. 79:1271-1281. (Pubitemid 40053909)
47. Szabo, G., S. Chang, and A. Dolganiuc. 2007. Altered innate immunity in chronic hepatitis C infection: cause or effect? Hepatology 46:1279-1290.
48. Szabo, G., and A. Dolganiuc. 2008. Hepatitis C core protein-the "core" of immune deception? J. Hepatol 48:8-11.
49. Widera, G., M. Austin, D. Rabussay, C. Goldbeck, S. W. Barnett, M. Chen, L. Leung, G. R. Otten, K. Thudium, M. J. Selby, and J. B. Ulmer. 2000. Increased DNA vaccine delivery and immunogenicity by electroporation in vivo. J. Immunol. 164:4635-4640. (Pubitemid 30238062)
50. Yamanaka, T., M. Uchida, and T. Doi. 2002. Innate form of HCV core protein plays an important role in the localization and the function of HCV core protein. Biochem. Biophys. Res. Commun. 294:521-527.
51. + T cells leads to impaired activation of Lck and Akt. J. Virol. 78:6409-6419.
52. Yao, Z. Q., S. N. Waggoner, M. W. Cruise, C. Hall, X. Xie, D. W. Oldach, and Y. S. Hahn. 2005. SOCS1 and SOCS3 are targeted by hepatitis C virus core/gC1qR ligation to inhibit T-cell function. J. Virol. 79:15417-15429.